Table 1.
Baseline characteristics of healthy controls (HC) and ME/CFS patients.
| HC (n = 52) | ME/CFS (n = 362) | p-value | |
|---|---|---|---|
| Male/femalea | 10/42 | 55/307 | 0.42 |
| Age (years) | 39 (15) | 42 (12) | 0.15 |
| Height (cm) | 173 (9) | 171 (9) | 0.12 |
| Weight (kg) | 74 (15) | 75 (18) | 0.66 |
| BMI (kg/m2) | 24.5 (4.3) | 25.3 (5.6) | 0.20 |
| BSA (m2) | 1.87 (0.21) | 1.86 (0.22) | 0.82 |
| Patients fulfilling CFS criteria | NA | 362 (100%) | |
| Patients with typical/atypical ME | NA | 262/101 (72/28%) | |
| Disease duration (years) # | NA | 11.5 (6–20) |
a
Chi-square 2 × 2 analysis; # Median (IQR); BMI: body mass index: BSA: body surface area (formula duBois); HC: healthy controls; ME/CFS: myalgic encephalomyelitis/chronic fatigue syndrome. A p-value of < 0.01 is considered statistically significant.